El grup de NanoBioPharma ha publicat, Topical pioglitazone nanoformulation for the treatment of atopic dermatitis: Design, characterization and efficacy in hairless mouse model

Espinoza L.C., Vera-García R., Silva-Abreu M., Domènech Ò., Badia J., Rodríguez-Lagunas M.J., Clares B., Calpena A.C. Pharmaceutics. Volume 12, Issue 3, March 2020, Article number 255. https://doi.org/10.3390/pharmaceutics12030255